60
Views
15
CrossRef citations to date
0
Altmetric
Original Research

Effects of early treatment with zofenopril in patients with myocardial infarction and metabolic syndrome: the SMILE Study

, &
Pages 665-671 | Published online: 06 Jun 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Claudio Borghi, Stefano Omboni, Giorgio Reggiardo, Stefano Bacchelli, Daniela Degli Esposti & Ettore Ambrosioni. (2018) Efficacy of zofenopril in combination with amlodipine in patients with acute myocardial infarction: a pooled individual patient data analysis of four randomized, double-blind, controlled, prospective studies. Current Medical Research and Opinion 34:10, pages 1869-1874.
Read now
Claudio Borghi, Stefano Bacchelli & Daniela Degli Esposti. (2012) Long-term clinical experience with zofenopril. Expert Review of Cardiovascular Therapy 10:8, pages 973-982.
Read now
G. Carlucci, L. Di Federico & P. Iuliani. (2010) Simultaneous Determination of Zofenopril and Hydrochlorothiazide in Tablets Using Derivative UV Spectrophotometry. Analytical Letters 43:16, pages 2609-2617.
Read now

Articles from other publishers (12)

Claudio Borghi & Stefano Omboni. (2020) Angiotensin-Converting Enzyme Inhibition: Beyond Blood Pressure Control—The Role of Zofenopril. Advances in Therapy 37:10, pages 4068-4085.
Crossref
Claudio BorghiStefano OmboniGiorgio ReggiardoStefano BacchelliDaniela Degli EspostiEttore Ambrosioni on behalf of the SMILE Working Proj. (2017) Efficacy of Ace Inhibition with Zofenopril, Lisinopril, or Ramipril in Postacute Myocardial Infarction Patients With or Without Metabolic Syndrome: A Pooled Individual Data Analysis of Four Randomized, Double-Blind, Controlled, Prospective Studies. Metabolic Syndrome and Related Disorders 15:6, pages 312-318.
Crossref
Laura Sbârcea, Lucreţia Udrescu, Ionuţ Ledeţi, Zoltan Szabadai, Adriana Fuliaş & Claudiu Sbârcea. (2015) β-Cyclodextrin inclusion complexes of lisinopril and zofenopril. Journal of Thermal Analysis and Calorimetry 123:3, pages 2377-2390.
Crossref
O Pechánová, Z V Varga, M Cebová, Z Giricz, P Pacher & P Ferdinandy. (2015) Cardiac NO signalling in the metabolic syndrome. British Journal of Pharmacology 172:6, pages 1415-1433.
Crossref
M. G Bubnova. (2013) Capacities of the current angiotensin-converting enzyme inhibitor zofenopril in clinical practice: cardioprotective, anti-ischemic, and antiatherogenic effects. CardioSomatics 4:1, pages 62-71.
Crossref
M. G. Bubnova. (2013) POTENTIAL OF THE MODERN ACE INHIBITOR ZOFENOPRIL IN CLINICAL PRACTICE: CARDIOPROTECTIVE, ANTI-ISCHEMIC, AND ANTIATHEROGENIC EFFECTS. Cardiovascular Therapy and Prevention 12:1, pages 102-110.
Crossref
C. Napoli. (2011) Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease. Cardiovascular Therapy and Prevention 10:6, pages 99-104.
Crossref
Jiri Parenica, Monika Pavkova Goldbergova, Petr Kala, Jiri Jarkovsky, Martin Poloczek, Jan Manousek, Krystyna Prymusova, Lenka Kubkova, Daniela Tomcikova, Ondrej Toman, Martin Tesak, Josef Tomandl, Anna Vasku & Jindrich Spinar. (2010) ACE gene insertion/deletion polymorphism has a mild influence on the acute development of left ventricular dysfunction in patients with ST elevation myocardial infarction treated with primary PCI. BMC Cardiovascular Disorders 10:1.
Crossref
A Tung. (2010) Anaesthetic considerations with the metabolic syndrome. British Journal of Anaesthesia 105, pages i24-i33.
Crossref
Giuseppe Carlucci, Lucia Di Federico & Piera Iuliani. (2010) HPLC-DAD method for the simultaneous determination of zofenopril and hydrochlorothiazide in oral pharmaceutical formulations. Journal of Separation Science 33:12, pages 1717-1722.
Crossref
Marco I Perez, Vijaya M Musini & James M Wright. (2009) Effect of early treatment with anti-hypertensive drugs on short and long-term mortality in patients with an acute cardiovascular event. Cochrane Database of Systematic Reviews.
Crossref
Claudio Napoli. (2009) Safety and Efficacy of the bi-Sulfydryl ACE-Inhibitor Zofenopril in the Management of Cardiovascular Disease. Clinical Medicine. Therapeutics 1, pages CMT.S2796.
Crossref